PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Center for Cancer Research · Whitehead Institute for Biomedical Research · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,209
total citations
- FWCI
- 30.81
- Percentile
- 100%
- References
- 38
Citations per year
Authors
8- YSYasemin Sancak
Center for Cancer Research, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- CCCarson C. Thoreen
Center for Cancer Research, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- TRTimothy R. Peterson
Center for Cancer Research, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- RARobert A. Lindquist
Center for Cancer Research, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- SASeong A. Kang
Center for Cancer Research, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
Topics & keywords
Topics
Keywords
- RHEB
- mTORC1
- P70-S6 Kinase 1
- Biology
- Cell biology
- Protein kinase B
- PI3K/AKT/mTOR pathway
- mTORC2
No related works found for this paper.